 Combination therapy for a complex disease (polypharmacology) is suggested in this field since one active pharmaceutical ingredient (API) aimed at one target may not effect the entire disease module.The concept of disease modules can be used to aid in drug discovery, drug design, and the development of biomarkers for disease detection.There can be a variety of ways to identifying drugs using network pharmacology; a simple example of this is the "guilt by association" method.